Zivo Bioscience Inc. (ZIVO)

NASDAQ: ZIVO · IEX Real-Time Price · USD
3.88
-0.06 (-1.62%)
At close: Aug 11, 2022 4:00 PM
3.93
+0.05 (1.29%)
After-hours: Aug 11, 2022 4:00 PM EDT
-1.62%
Market Cap 36.55M
Revenue (ttm) n/a
Net Income (ttm) -9.20M
Shares Out 9.42M
EPS (ttm) -1.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,263
Open 3.90
Previous Close 3.94
Day's Range 3.80 - 4.01
52-Week Range 2.37 - 7.90
Beta -0.06
Analysts Buy
Price Target 9.18 (+136.6%)
Earnings Date Aug 15, 2022

About ZIVO

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. It operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal h... [Read more...]

Industry Personal Products
CEO Andrew Dahl
Employees 10
Stock Exchange NASDAQ
Ticker Symbol ZIVO
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for ZIVO stock is "Buy." The 12-month stock price forecast is 9.18, which is an increase of 136.60% from the latest price.

Price Target
$9.18
(136.60% upside)
Analyst Consensus: Buy
Stock Forecasts

News

ZIVO Reports that USDA Claims Regulatory Jurisdiction for New Coccidiosis Treatment

BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--ZIVO Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product ...

Zivo Bioscience Joins Russell Microcap® Index

BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--ZIVO Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product ...

Zivo Bioscience Regains Compliance Following Receipt of Noncompliance Notice from Nasdaq

BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--ZIVO Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product ...

ZIVO Bioscience Names Chairman John B. Payne as President and CEO

KEEGO HARBOR, Mich.--(BUSINESS WIRE)--ZIVO Bioscience, Inc. (NASDAQ: ZIVO) (“ZIVO” or the “Company”), a biotech/agtech R&D company engaged in the development and commercialization of therapeutic, medici...

Zivo Bioscience, Inc. to Participate in the Global AgTech Virtual Conference Presented by Maxim Group LLC and hosted ...

KEEGO HARBOR, Mich., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ: ZIVO, ZIVOW) (“ZIVO” and the “Company”), a biotech/agtech R&D company engaged in the development and commercializati...

Weblink Instructions for the Annual Meeting of Shareholders of Zivo Bioscience, Inc.

KEEGO HARBOR, Mich., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ: ZIVO, ZIVOW) (“ZIVO” and the “Company”), a biotech/agtech R&D company engaged in the development and commercializati...

ZIVO Stock: 6 Things to Know About Biotech ZIVO Bioscience as Shares Rocket on No News

ZIVO Bioscience (ZIVO) stock is rocketing higher on Friday despite no news concerning the company in what appears to be a pump and dump. The post ZIVO Stock: 6 Things to Know About Biotech ZIVO Bioscien...

ZIVO Stock: 8 Things to Know About Biotech Play Zivo Bioscience as Shares Rocket 155%+

Zivo Bioscience (ZIVO) stock is rocketing higher on Monday with heavy trading despite a lack of news coming from the company today. The post ZIVO Stock: 8 Things to Know About Biotech Play Zivo Bioscien...

Zivo Bioscience, Inc. Issues Letter to Shareholders

KEEGO HARBOR, Mich., Aug. 17, 2021 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ: ZIVO, ZIVOW) (“ZIVO” and the “Company”), a biotech/agtech R&D company engaged in the development and commercializati...

ZIVO Bioscience to Present at the Q3 Virtual Investor Summit

Keego Harbor, Michigan--(Newsfile Corp. - August 11, 2021) - ZIVO Bioscience (NASDAQ: ZIVO) today announced that Andrew Dahl will be attending the Q3 Virtual Investor Summit.  Event Q3 Investor Summit D...

Zivo Bioscience, Inc. Announces Closing of Underwriters' Partial Exercise of Over-Allotment Option in Connection with...

KEEGO HARBOR, Mich., July 02, 2021 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ: ZIVO, ZIVOW) (“ZIVO” and the “Company”), a biotech/agtech R&D company engaged in the development and commercializati...

ZIVO Bioscience to Present at the LD Micro Virtual Invitational Conference on June 9, 2021

KEEGO HARBOR, Mich., June 02, 2021 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (NASDAQ:ZIVO), a biotech/agtech R&D company engaged in the development and commercialization of therapeutic, medicinal and nu...

Zivo Bioscience, Inc. Announces Closing of Upsized $13.8 Million Public Offering and Uplisting to Nasdaq

KEEGO HARBOR, Mich., June 02, 2021 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ: ZIVO, ZIVOW) (“ZIVO” and the “Company”), a biotech/agtech R&D company engaged in the development and commercializati...

Zivo Bioscience, Inc. Announces Pricing of Upsized $13.8 Million Public Offering and Up-listing to Nasdaq

KEEGO HARBOR, Mich., May 27, 2021 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (OTCMKTS:ZIVO) a biotech/agtech R&D company engaged in the development and commercialization of nutritional/nutraceutical prod...

ZIVO Bioscience Announces US Patent Office Notice of Allowance for Administration of Proprietary Algal Biomass to Sup...

KEEGO HARBOR, Mich., April 26, 2021 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (OTCMKTS:ZIVO) a biotech/agtech R&D company engaged in the development and commercialization of nutritional/nutraceutical pr...

ZIVO Bioscience to Participate in Maxim Group's Inaugural Emerging Growth Virtual Conference

KEEGO HARBOR, Mich., March 11, 2021 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (OTCQB: ZIVO), a biotech/agtech R&D company engaged in the development and commercialization of therapeutic and additive pro...

ZIVO Bioscience Successfully Confirms Poultry Growth Promotion and Feed Conversion Ratio Improvements in Typical Prod...

KEEGO HARBOR, MI / ACCESSWIRE / January 11, 2021 / ZIVO Bioscience, Inc. (OTCQB:ZIVO) a biotech/agtech R&D company engaged in the development and commercialization of therapeutic/additive product candid...

Zivo Bioscience Names Keith R. Marchiando as Chief Financial Officer

KEEGO HARBOR, MI / ACCESSWIRE / January 7, 2021 / ZIVO Bioscience, Inc. (OTCMQB:ZIVO) a biotech/agtech R&D company engaged in the development and commercialization of therapeutic, food and feed additive...